chr1-155235790-C-A
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000157.4(GBA1):c.1279G>T(p.Glu427*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. E427E) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000157.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GBA1 | NM_000157.4 | c.1279G>T | p.Glu427* | stop_gained | 9/11 | ENST00000368373.8 | NP_000148.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GBA1 | ENST00000368373.8 | c.1279G>T | p.Glu427* | stop_gained | 9/11 | 1 | NM_000157.4 | ENSP00000357357.3 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Gaucher disease Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 21, 2016 | The p.Glu427X variant in GBA has not been previously reported in patients with G aucher disease and was absent from large population studies. This nonsense varia nt leads to a premature termination codon at position 427, which is predicted to lead to a truncated or absent protein. Biallelic mutations (including loss of f unction) in the GBA gene cause Gaucher disease. In summary, this variant meets c riteria to be classified as likely pathogenic for Gaucher disease in an autosoma l recessive manner based upon predicted null effect. Please note that, due to th e technical limitations of the next generation sequencing and Sanger confirmatio n assays, the GBA pseudogene cannot be reliably avoided. Therefore, before makin g clinical decisions regarding this variant, further testing via targeted assays that guarantee avoidance of GBA pseudogene would be required to confirm the pre sence of this variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at